China · Investor

Eisai

Last cheque observed Nov 2002. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietCorporate VC

Series BBiotechnologyHealth CarePharmaceutical

Cheques on record
0%of best year0cheques in 12 months, 1 on record
Since the last cheque8760days00hrs00min00sec
Median round$10MRounds led0 of 1
Pitch Eisai

Eisai highlights

  1. 01

    1 rounds on record

  2. 02

    Mostly Series B: 100% of its rounds

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyHealth CarePharmaceutical
Based in
China
Cold pitches
Not stated

The record

Every round we can evidence, newest first1 appearances

  1. 2002

    1 round

  2. Nov
    NeuroGenetic PharmaceuticalsSeries B · US$10MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Companies it bought

Acquisitions by the firm itself

AkaRx$255MJan 2010

Quick answers about Eisai

What does Eisai invest in?

Eisai invests most often at Series B (100% of the rounds on record), in sectors such as Biotechnology, Health Care and Pharmaceutical.

How active is Eisai?

1 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2002.

How big are Eisai's cheques?

The median round it joins is $10M.

Is Eisai investing now?

No investments in the last 12 months; the latest was in Nov 2002.

What kind of investor is Eisai?

Eisai is a corporate VC based in China.

When was Eisai founded?

Eisai was founded in 1941.

Where does this information on Eisai come from?

From public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it